Back Login to subscribe 🔔 Set Alert

CHRS Coherus Oncology, Inc. Common Stock

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
CHRS Fundamental Data
Loading...
CHRS Options Chain
Put/Call Ratio
—
—
Expected Move
—
—
Max Pain
—
—
ATM Call Break-even
—
—
ATM Put Break-even
—
—
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
CHRS Insider Transactions
Loading insider data…
CHRS News
Date Headline Sentiment
Coherus Oncology shares are trading lower after the company reported mixed Q1 financial results.
97.19%
Coherus BioSciences Q1 Adj. EPS $(0.25) Beats $(0.27) Estimate, Sales $12.310M Miss $14.342M Estimate
64.15%
Guggenheim Initiates Coverage On Coherus Oncology with Buy Rating, Announces Price Target of $12
62.96%
Earnings Scheduled For May 11, 2026
86.61%